Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of British Columbia

$24,638.00

Designing a biomedical cutter for heart valve leaflets

EF 2018-19

Résumé
Vesalius Cardiovascular is a biomedical device venture designing and developing surgical implants and*accessories for mitral valve regurgitation.*For patients with mitral regurgitation for whom mitral valve repair is not possible, mitral valve replacement*becomes necessary. The current gold standard therapy is surgical mitral valve replacement, an open-heart*operation. But because of the risk of heart surgery, many patients*cannot be safely treated, and so industry is working toward percutaneous mitral valve replacement, which*means the valve is replaced through a catheter rather than with open surgery. This technique is called*Transcatheter Mitral Valve Replacement (TMVR).*Attempts to implant a transcatheter mitral valve have all been subject to a serious and common complication*related to the technique called Left Ventricular Outflow Tract Obstruction (LVOTO), a fatal complication.*Vesalius approach is to replicate what is done surgically to avoid this problem, but percutaneously. At surgery,*the problem is avoided by dividing the anterior leaflet from its attachment beside the aortic outflow valve.*Vesalius solution is a percutaneous tool for the creation of a precise cut in the anterior leaflet of the mitral*valve, through which a transcatheter valve may then be expeditiously implanted over*the same wire that has been used to create the cut. The expanded replacement valve moves*the anterior leaflet away from the aortic outflow valve, and LVOTO is avoided.
Programme
Engage Grants Program
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
528766-2018
Name nom
Salcudean, Septimiu
Department département
Electrical and Computer Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
24638
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Designing a biomedical cutter for heart valve leaflets
Keyword
NSERC
Application summary
Vesalius Cardiovascular is a biomedical device venture designing and developing surgical implants and*accessories for mitral valve regurgitation.*For patients with mitral regurgitation for whom mitral valve repair is not possible, mitral valve replacement*becomes necessary. The current gold standard therapy is surgical mitral valve replacement, an open-heart*operation. But because of the risk of heart surgery, many patients*cannot be safely treated, and so industry is working toward percutaneous mitral valve replacement, which*means the valve is replaced through a catheter rather than with open surgery. This technique is called*Transcatheter Mitral Valve Replacement (TMVR).*Attempts to implant a transcatheter mitral valve have all been subject to a serious and common complication*related to the technique called Left Ventricular Outflow Tract Obstruction (LVOTO), a fatal complication.*Vesalius approach is to replicate what is done surgically to avoid this problem, but percutaneously. At surgery,*the problem is avoided by dividing the anterior leaflet from its attachment beside the aortic outflow valve.*Vesalius solution is a percutaneous tool for the creation of a precise cut in the anterior leaflet of the mitral*valve, through which a transcatheter valve may then be expeditiously implanted over*the same wire that has been used to create the cut. The expanded replacement valve moves*the anterior leaflet away from the aortic outflow valve, and LVOTO is avoided.